Crucible Therapeutics Limited
Company Profile
live
MicroCrucible Therapeutics Limited
14690230•Private Limited With Share Capital
The Innovation Centre, 217 Portobello, Sheffield, S14DP
Get Full Access
Incorporated
27/02/2023
Company Age
3 years
Directors
6
Employees
—
SIC Code
72110
Risk
low risk
Company Overview
Registration, classification & business activity
Crucible Therapeutics Limited (14690230) is a private limited with share capital incorporated on 27/02/2023 (3 years old) and registered in sheffield, S14DP. The company operates under SIC code 72110 and is classified as Micro.
Private Limited With Share Capital
SIC: 72110
Micro
Incorporated 27/02/2023
S14DP
Financial Overview
Total Assets
£1.33M
Liabilities
£279.8K
Net Assets
£1.05M
Cash
£1.26M
Key Metrics
6
Directors
8
Shareholders
2
Patents
Board of Directors
5
Name
Position
director
director
director
director
director
Filed Documents
27
Document Name
Category
Date
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:17-04-2026
Accounts With Accounts Type Small
Category:Accounts
Date:07-11-2025
Appoint Person Secretary Company With Name Date
Category:Officers
Date:14-08-2025
Termination Secretary Company With Name Termination Date
Category:Officers
Date:14-08-2025
Confirmation Statement With Updates
Category:Confirmation Statement
Date:17-04-2025
Capital Allotment Shares
Category:Capital
Date:17-04-2025
Appoint Person Director Company With Name Date
Category:Officers
Date:11-11-2024
Termination Director Company With Name Termination Date
Category:Officers
Date:08-11-2024
Accounts With Accounts Type Small
Category:Accounts
Date:18-10-2024
Confirmation Statement With Updates
Category:Confirmation Statement
Date:05-04-2024
Notification Of A Person With Significant Control
Category:Persons With Significant Control
Date:26-03-2024
Notification Of A Person With Significant Control
Category:Persons With Significant Control
Date:26-03-2024
Withdrawal Of A Person With Significant Control Statement
Category:Persons With Significant Control
Date:25-03-2024
Capital Allotment Shares
Category:Capital
Date:21-03-2024
Confirmation Statement With Updates
Category:Confirmation Statement
Date:28-02-2024
Notification Of A Person With Significant Control Statement
Category:Persons With Significant Control
Date:19-10-2023
Capital Allotment Shares
Category:Capital
Date:19-10-2023
Capital Allotment Shares
Category:Capital
Date:19-10-2023
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:19-10-2023
Appoint Person Secretary Company With Name Date
Category:Officers
Date:15-10-2023
Resolution
Category:Resolution
Date:11-10-2023
Appoint Person Director Company With Name Date
Category:Officers
Date:10-10-2023
Memorandum Articles
Category:Incorporation
Date:10-10-2023
Appoint Person Director Company With Name Date
Category:Officers
Date:06-10-2023
Appoint Person Director Company With Name Date
Category:Officers
Date:06-10-2023
Appoint Person Director Company With Name Date
Category:Officers
Date:06-10-2023
Incorporation Company
Category:Incorporation
Date:27-02-2023
Innovate Grants
1
This company received a grant of £1109150.0 for Targeting Rna Nuclear Export: A Disease-Modifying Treatment For Als/Ftd. The project started on 01/05/2025 and ended on 30/04/2027.
Risk Assessment
low risk
International Score
Future Factor
good
Performance Rating
Accounts
Typesmall company
Due Date30/11/2026
Filing Date05/11/2025
Latest Accounts28/02/2025
Trading Addresses
The Innovation Centre, 217 Portobello, Sheffield, S14DPRegistered
Related Companies
10
Contact
The Innovation Centre, 217 Portobello, Sheffield, S14DP